KR

Kapil Rajinder Khanna

Active Director Director DIN 00309717
DIN 00309717 First appointment Nov 1997 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Nov 1997
Shareholding value •••• Premium profile

About Kapil Rajinder Khanna

Data last updated:

Kapil Rajinder Khanna is a Director at Embassy Biogenic (India) Private Limited (since 2004), Director at Embassy Silicones India Private Limited (since 1997) and Partner at Option Exports Llp (since 2017), and holds 1 more current directorship. The companies operate in Chemicals and Materials, Business Services and Trading. The 4 current companies with reported revenue have a combined latest revenue of ₹55.15 Cr; the largest is Embassy Biogenic (India) Private Limited at ₹27.87 Cr (FY 2025). Earlier, Kapil Rajinder Khanna was a Director at Duchem Specialities India Private Limited (2016–2017) and Director at Option Exports Private Limited (2001–2017).

DIN 00309717
Primary Designation Director
Industry Chemicals and Materials
First Appointment 17 Nov 1997
Oldest Company Age 28 yrs
Largest company Embassy Biogenic (India) Private Limited · ₹27.87 Cr (FY 2025)
Combined revenue ₹55.15 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Mar 20042004₹27.87 Cr (FY 2025)Active
Director17 Nov 19971997₹27.05 Cr (FY 2025)Active
Partner24 Mar 20172017₹21.3 Lakh (FY 2023)Active
Designated Partner03 Mar 20102010₹2.2 Lakh (FY 2023)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Apr 20162015₹5.46 Cr (FY 2020)Active
Option Exports Private Limited U51900MH1999PTC120857
Director30 Mar 20011999₹55.8 Lakh (FY 2016)Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Kapil Rajinder Khanna

Directorship timeline

Open interactive timeline →
Option Exports Llp
Embassy Silicones India Private Limited
Embassy Biogenic (India) Private Limited
Embassy Procoats India Llp
Premium access

Shareholding and investment profile for Kapil Rajinder Khanna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kapil Rajinder Khanna

Kapil Rajinder Khanna currently holds 4 directorships: Embassy Biogenic (India) Private Limited (Director, since 26 Mar 2004, revenue ₹27.87 Cr (FY 2025)); Embassy Silicones India Private Limited (Director, since 17 Nov 1997, revenue ₹27.05 Cr (FY 2025)); Option Exports Llp (Partner, since 24 Mar 2017, revenue ₹21.3 Lakh (FY 2023)); Embassy Procoats India Llp (Designated Partner, since 03 Mar 2010, revenue ₹2.2 Lakh (FY 2023)).

Kapil Rajinder Khanna was first appointed on 17 Nov 1997 as Director at Embassy Silicones India Private Limited. The most recent appointment on record is 24 Mar 2017 at Option Exports Llp.

The 4 current companies of Kapil Rajinder Khanna that report revenue have a combined latest revenue of ₹55.15 Cr: Embassy Biogenic (India) Private Limited ₹27.87 Cr (FY 2025); Embassy Silicones India Private Limited ₹27.05 Cr (FY 2025); Option Exports Llp ₹21.3 Lakh (FY 2023); Embassy Procoats India Llp ₹2.2 Lakh (FY 2023).

Kapil Rajinder Khanna held 2 earlier board appointments: Duchem Specialities India Private Limited (Director, 04 Apr 2016 to 08 May 2017); Option Exports Private Limited (Director, 30 Mar 2001 to 23 Mar 2017).

The current boards of Kapil Rajinder Khanna's companies include Pinky Kapil Khanna (Embassy Biogenic (India) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available